Deep Learning for Longitudinal Medical Imaging: A Scoping Review

📅 2026-09-29
📈 Citations: 0
✨ Influential: 0
📄 PDF
🤖 AI Summary
Longitudinal medical image analysis lacks a systematic review, leaving its technical challenges and scientific landscape unclear. This study addresses this gap by conducting a scoping review of 102 deep learning-related studies published between 2018 and 2025, systematically synthesizing their methodological architectures, clinical applications, and validation strategies. The findings reveal that CNN-LSTM serves as the predominant architecture, MRI as the primary modality, and classification tasks within neurology and ophthalmology as the dominant applications. This work provides the first comprehensive delineation of the technical landscape in this field while identifying the critical bottleneck of severely insufficient external validation. Ultimately, it offers clear directions for advancing the clinical translation of artificial intelligence models applied to longitudinal medical imaging.
📝 Abstract
Longitudinal medical imaging analysis is a cornerstone of modern medical practice and patient care. Deep learning applied to longitudinal imaging offers wide potential to enhance diagnosis and track disease progression by capturing spatial changes over time. With major advances in single-timepoint deep learning for imaging, there has been growing interest in longitudinal image analysis, given its increased clinical relevance, though technical challenges remain. Several recent innovations may lead to a new era of multi-timepoint image evaluation, yet the scientific landscape, recent progress, and areas of need remain under-characterized. To address this gap, we conducted a scoping review of deep learning methodologies applied to longitudinal medical imaging, yielding 102 studies published between 2018 and 2025. Neurological disorders (48%) and ophthalmic conditions (12%) were the most common clinical applications, with MRI serving as the predominant imaging modality (67%). Sequential feature modeling approaches combining convolutional neural networks (CNNs) with temporal models (LSTM/RNN) were the most frequent methodology (40%), followed by direct feature aggregation across timepoints (23%). Most studies targeted classification tasks (56%), while external validation was performed in only 24% of studies. Our findings highlight that deep learning-based longitudinal imaging analysis remains a promising field, though newer temporal architectures and larger datasets may improve success and clinical adoption of these tools.
Problem

Research questions and friction points this paper is trying to address.

Deep Learning
Longitudinal Medical Imaging
Disease Progression
Scoping Review
Innovation

Methods, ideas, or system contributions that make the work stand out.

Longitudinal Medical Imaging
Deep Learning
Sequential Feature Modeling
Temporal Architectures
Scoping Review
🔎 Similar Papers
No similar papers found.
F
Francesca Mussa
Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States
D
Divyanshu Tak
Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States; Dana-Farber Cancer Institute, Boston, MA, United States
A
Atlas H. Avval
Center for Intelligent Imaging, Department of Radiology & Biomedical Imaging, University of California, San Francisco (UCSF)
S
Sarah Brueningk
Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland; Department of Digital Medicine, University of Bern, Bern, Switzerland
R
Ray H. Mak
Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States; Dana-Farber Cancer Institute, Boston, MA, United States
H
Hugo J. W. L. Aerts
Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States; Dana-Farber Cancer Institute, Boston, MA, United States
A
Andreas M Rauschecker
Center for Intelligent Imaging, Department of Radiology & Biomedical Imaging, University of California, San Francisco (UCSF)
B
Benjamin H. Kann
Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, United States; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States; Dana-Farber Cancer Institute, Boston, MA, United States